ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AZN Astrazeneca Plc

12,106.00
-20.00 (-0.16%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -20.00 -0.16% 12,106.00 12,120.00 12,122.00 12,190.00 12,024.00 12,080.00 999,558 16:35:02
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 45.81B 5.96B 3.8415 31.55 187.98B

AGM Poll Votes

30/04/2003 5:24pm

UK Regulatory


RNS Number:5919K
AstraZeneca PLC
30 April 2003


FOR IMMEDIATE RELEASE:

                                ASTRAZENECA PLC

                     ANNUAL GENERAL MEETING : 30 APRIL 2003


AstraZeneca PLC announced the results of the polls taken at its Annual General
Meeting today in respect of Items 5(e), 9 and 10 on the Agenda, as follows:


Item 5(e): Ordinary Resolution to re-elect Sir Peter Bonfield as a Director:

VOTES FOR:            830,994,339     (95.57%)

VOTES AGAINST:        38,475,456      (4.43%)

This Resolution was passed as an Ordinary Resolution at the AGM.



Percy Barnevik, Chairman of AstraZeneca PLC, said "My Board colleagues and I are
delighted that Sir Peter Bonfield has been re-elected as a Director with such
overwhelming support following the poll held at today's Annual General Meeting.
Sir Peter is making a key contribution to AstraZeneca in his role both as the
senior Non-Executive Director and also as Chairman of the Remuneration
Committee."



Item 9: Special Resolution to authorise the Directors to allot unissued shares:

VOTES FOR:            813,215,344     (95.90%)

VOTES AGAINST:        34,776,305      (4.10%)

This Resolution was passed as a Special Resolution at the AGM.




Item 10: Special Resolution to authorise the Company to purchase its own shares:

VOTES FOR:            890,748,684     (99.86%)

VOTES AGAINST:        1,261,770       (0.14%)

This Resolution was passed as a Special Resolution at the AGM.



Under the Company's Articles of Association, voting on all Special Resolutions
is conducted by poll.

G H R Musker
Company Secretary

30 April 2003


                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

RAGEAKLEDADDEFE

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart

Your Recent History

Delayed Upgrade Clock